Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome, resulting from a translocation between chromosomes 9 and 22, which produces the BCR-ABL fusion gene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.